Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Healthcare REIT filings document the reporting framework for a NYSE-listed healthcare REIT with common stock and an operating partnership. Recent 8-K reports furnish earnings releases, financial-position updates, supplemental operating data, distribution authorizations and Regulation FD materials tied to the company's real estate portfolio and segment performance.
Other filings cover material financing arrangements, including credit-facility amendments and an at-the-market equity offering program, as well as proxy disclosures on board governance, executive compensation and stockholder voting matters. Leadership-transition reports and related compensatory arrangements are documented through Form 8-K and amended Form 8-K disclosures.
American Healthcare REIT (NYSE:AHR) filed a Form 4 reporting a routine insider transaction. Director Marvin R. O'Quinn was granted 3,042 shares of restricted common stock on June 25, 2025 upon his re-election to the board. The grant carries a cost basis of $0 and is scheduled to vest on June 25, 2026. Following the award, O'Quinn’s beneficial ownership increases to 18,062 shares. No shares were sold or disposed of, and the filing does not reference a Rule 10b5-1 trading plan. The disclosure represents typical board compensation and does not indicate any material change in insider sentiment or the company’s financial condition.
American Healthcare REIT, Inc. (AHR) – Form 4 insider update
On 25 Jun 2025, director Mathieu B. Streiff received 3,042 restricted common shares at $0.00 as part of his re-election compensation. These shares will vest on 25 Jun 2026. After the grant, Streiff’s direct holdings rise to 32,377 shares, while he also indirectly controls 157,402 shares through the Streiff Family Trust, bringing total reported beneficial ownership to roughly 189,779 shares.
No sales, option exercises, or derivative positions were disclosed, and the filing reflects routine board compensation rather than a market transaction. The event marginally increases insider ownership but is unlikely to affect AHR’s share float, liquidity, or near-term valuation.
Form 4 overview: On June 25, 2025, American Healthcare REIT, Inc. (ticker AHR) granted Director Wilbur H. Smith III an equity award of 3,042 shares of restricted common stock in conjunction with his re-election to the board.
Key transaction terms:
- Type: Equity grant (restricted stock); reported as an “A” (acquired) transaction code.
- Price: $0 per share, indicating a non-cash, board-approved compensation grant.
- Vesting: Shares vest in full on June 25, 2026, creating a one-year lock-in that aligns director incentives with shareholder value over the next 12 months.
Ownership impact: Following the award, Smith’s total beneficial ownership increased to 32,419 common shares. The grant adds approximately 3,000 shares, modestly expanding his stake and signalling continued board-level alignment with the company’s long-term performance.
Materiality: The filing represents routine director compensation and does not disclose any open-market purchases or sales, option exercises, or derivative activity. No earnings data, financial guidance, or strategic transactions are included in this report.
American Healthcare REIT, Inc. (AHR) filed a Form 4 disclosing that director Valerie Richardson received an equity grant on 25 June 2025.
- Transaction: 3,042 shares of restricted common stock were awarded (coded “A”) at a price of $0.
- Vesting schedule: The shares vest in full on 25 June 2026.
- Post-transaction ownership: Richardson now beneficially owns 18,062 common shares, held directly.
The filing reflects routine board compensation rather than an open-market purchase. While it slightly increases insider ownership, the size of the award is modest and does not materially change overall share count or insider control.
American Healthcare REIT, Inc. (AHR) – Form 4 insider filing
Director Dianne Hurley received 3,042 restricted shares of AHR common stock on 25 Jun 2025 upon her re-election to the board. The grant was recorded at $0 cost and will vest on 25 Jun 2026. Following this award, Hurley’s direct beneficial ownership increased to 31,443 shares. No shares were sold or transferred, and no derivative securities were involved. The transaction was coded “A,” indicating a stock award rather than an open-market purchase or sale.
The filing reflects routine board compensation, resulting in minor dilution and a modest increase in insider ownership.
American Healthcare REIT, Inc. (AHR) – Form 4 insider filing
Director Brian J. Flornes reported the receipt of 3,042 shares of restricted common stock on 25 June 2025 following his re-election to the board. The grant was recorded under transaction code “A” (acquisition) at an assigned price of $0.00, indicating a non-cash equity award rather than an open-market purchase.
The awarded shares will vest on 25 June 2026, one year after the grant date. After the transaction, Mr. Flornes’ total direct beneficial ownership increased to 30,426 common shares. No derivative securities, dispositions, or sales were reported.
This filing represents a routine director compensation grant and does not introduce new debt, equity financing, or earnings guidance. The transaction adds a modest 0.003% to AHR’s outstanding share count (based on ~100 million shares outstanding, if unchanged), limiting any dilution concerns. From a governance perspective, incremental ownership can further align the director’s incentives with shareholder interests.
American Healthcare REIT (AHR) filed a Form 4 disclosing that director Scott A. Estes received 3,042 restricted common shares on June 25 2025 upon his re-election to the board.
The grant was made at $0 cost and will vest on June 25 2026. Following the award, Estes' direct ownership increased to 18,895 shares, implying the new grant represents roughly 19 % of his post-transaction holdings.
No derivative securities, sales, or open-market purchases were reported, and the filing contains no additional financial information or risk disclosures.
American Healthcare REIT (NYSE:AHR) filed a Form 4 disclosing that Non-Executive Chairman and Director Jeffrey T. Hanson received 3,042 restricted common shares on 25 Jun 2025 following his re-election to the board. The grant was made at $0 cost and will vest in full on 25 Jun 2026.
Post-transaction, Hanson holds 41,808 shares directly and 85,163 shares indirectly through family trusts, retirement accounts and pension plans, bringing his total reported beneficial ownership to roughly 126,971 AHR shares. The filing also notes that securities held by NCT-107, LLC—a charitable foundation in which Hanson lacks pecuniary interest—will no longer be included in his Section 16 reports.
Form 144 Notice filed by Stefan K.L. Oh, an officer of American Healthcare REIT, indicating a proposed sale of 3,860 shares of common stock with an aggregate market value of $138,689.80 on the NYSE. The sale is scheduled for June 27, 2025.
The securities were originally acquired through an open market purchase on February 2, 2015, with cash payment. The company's total shares outstanding are 159,496,793. The sale will be executed through Charles Schwab & Co.
Key points:
- Sale represents approximately 0.002% of total shares outstanding
- Average price per share: $35.93
- No other securities were sold by the officer in the past 3 months
- Officer confirms no knowledge of undisclosed material adverse information